Patients with high-risk prostate cancer treated with curative intent are at an increased risk of
biochemical recurrence, metastatic progression and cancer-related death compared with …

Objectives To review the literature to determine the sensitivity and specificity of gallium‐68
prostate‐specific membrane antigen (68Ga‐PSMA) positron‐emission tomography (PET) for …

Background High-risk prostate cancer (PCa) patients have a high risk of biochemical
recurrence and metastatic progression following radical prostatectomy (RP). Objective To …

Biochemical recurrence (BCR) is a clinical challenge in prostate cancer (PCa) patients, as
recurrence localization guides subsequent therapies. The use of PET with prostate-specific …

Background Local ablative radiotherapy (aRT) of oligometastatic prostate cancer (PCa) is
very promising and has become a focus of current clinical research. Objective We …

Purpose This study aimed to develop and assess an automated segmentation framework
based on deep learning for metastatic prostate cancer (mPCa) lesions in whole-body [68Ga] …

Purpose This study aimed to (i) validate the Response Evaluation Criteria in PSMA (RECIP
1.0) criteria in a cohort of biochemically recurrent (BCR) prostate cancer (PCa) patients and …

Purpose Oligometastatic disease refers to a distinct state in patients with cancer
characterized by a low metastatic burden, with diagnosis being informed by a limited …

In accordance with the spectrum theory of metastatic disease, an oligometastatic clinical
state has been proposed as an intermediary step along the natural history of cancer with few …

Context Little is known about prostate-specific membrane antigen (PSMA) expression in
patients with cervical involvement of differentiated thyroid cancer (DTC). Objective We …